KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer
- DOI
- 10.1016/j.ccell.2026.10.003
- Published
- 2026-10
- Container
- Cancer Cell
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.ccell.2026.10.003,
title = {KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer},
author = {Yehan Zhang and Shijie Tang and Yi Zhang and Jiahui Liu and Xiaohan Shi and Yikai Li and Yunguang Li and Huan Wang and Chaoliang Zhong and Maoyuan Sun and Wenjie Li and Yiqin Zhu and Weiwei Yang and Yun Zhao and Shiwei Guo and Zhongjun Wu and Lin Wang and Gang Jin and Dong Gao},
year = {2026},
journal = {Cancer Cell},
doi = {10.1016/j.ccell.2026.10.003},
url = {https://doi.org/10.1016/j.ccell.2026.10.003}
}RIS
TY - JOUR TI - KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer AU - Yehan Zhang AU - Shijie Tang AU - Yi Zhang AU - Jiahui Liu AU - Xiaohan Shi AU - Yikai Li AU - Yunguang Li AU - Huan Wang AU - Chaoliang Zhong AU - Maoyuan Sun AU - Wenjie Li AU - Yiqin Zhu AU - Weiwei Yang AU - Yun Zhao AU - Shiwei Guo AU - Zhongjun Wu AU - Lin Wang AU - Gang Jin AU - Dong Gao PY - 2026 JO - Cancer Cell DO - 10.1016/j.ccell.2026.10.003 UR - https://doi.org/10.1016/j.ccell.2026.10.003 ER -
APA
Zhang, Y., Tang, S., Zhang, Y., Liu, J., Shi, X., Li, Y., Li, Y., Wang, H., Zhong, C., Sun, M., Li, W., Zhu, Y., Yang, W., Zhao, Y., Guo, S., Wu, Z., Wang, L., Jin, G., & Gao, D. (2026). KRASG12D-targeted therapy sensitivity depends on interferon signaling activation in pancreatic cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2026.10.003
Source records
- crossref · retrieved 2026-11-03T23:31:34.745Z